• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Nassmith Pharmaceuticals Inc. 12-Mar-99 - DETAIL

Letter Issue Date Company Name Issuing Office Subject
03/12/1999 Nassmith Pharmaceuticals, Inc. Los Angeles District Office Drug Products/CFR Deviations
Persons with disabilities having problems accessing the above pdf file may call 301-827-6567 for assistance